47.96
-0.06
(-0.12%)
May 21 - Close
NYSE
real-time data -
Disclaimer
Currency in USD
| Range | 47.74 - 48.30 |
| 52 week | 36.91 - 48.40 |
| Open | 48.09 |
| Vol / Avg. | 0.00/3.08M |
| Mkt cap | 16.39B |
| P/E | 14.30 |
| Div/yield | 0.30/2.52 |
| EPS | 3.35 |
| Shares | 341.82M |
| Beta | 0.72 |
| Inst. own | 88% |
Events
Jun 11, 2013
Cardinal Health, Inc. at Goldman Sachs Healthcare Conference
- 11:40AM EDT -
May 14, 2013
Cardinal Health, Inc. at Bank of America Merrill Lynch Health Care Conference
May 2, 2013
Q3 2013 Cardinal Health, Inc. Earnings Conference Call
Mar 13, 2013
Cardinal Health, Inc. at Barclays Healthcare Conference - Breakout Session
Mar 13, 2013
Cardinal Health, Inc. at Barclays Healthcare Conference
Mar 5, 2013
Cardinal Health, Inc. at Cowen Health Care Conference
|
More events from DailyFinance »
|
Key stats and ratios
| Q1 (Mar '13) | 2012 | |
| Net profit margin | 1.41% | 0.99% |
| Operating margin | 1.93% | 1.67% |
| EBITD margin | - | 2.03% |
| Return on average assets | 5.40% | 4.54% |
| Return on average equity | 20.76% | 17.70% |
| Employees | 32,500 | - |
| Carbon Disclosure Rating | - | 75/100 |
Address
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
About Company - Wikipedia
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
Cardinal Health, Inc. is a healthcare services company providing products and services that help pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. During the fiscal year ended June 30, 2012 (fiscal 2012), the Company operated in two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare, and consumer products through its pharmaceutical distribution business to retailers. The Medical segment distributes a range of medical, surgical and laboratory products to hospitals, surgery centers, laboratories, physician offices and other healthcare providers. Effective March 18, 2013, it merged with AssuraMed Holding Inc.
Officers and directors
| George S. Barrett | Chairman of the Board, Chief Executive Officer | |
| Jeffrey W. Henderson | Chief Financial Officer | |
| Donald M. Casey Jr. | Chief Executive Officer - Medical Segment | |
| Michael C. Kaufmann | Chief Executive Officer - Pharmaceutical Segment | |
| Stephen T. Falk | Executive Vice President, General Counsel, Corporate Secretary | |
| Mark R. Blake | Executive Vice President - Strategy and Corporate Development | |
| Craig S. Morford | Chief Legal and Compliance Officer | |
| Carole S. Watkins | Chief Human Resources Officer | |
| Colleen F. Arnold | Independent Director | |
| Glenn A. Britt | Independent Director |
